SI1997506T1 - Uporaba CK2 inhibitorja za zdravljenje in kemosenzibilizacijo refraktarnih tumorjev na zdravila proti raku - Google Patents

Uporaba CK2 inhibitorja za zdravljenje in kemosenzibilizacijo refraktarnih tumorjev na zdravila proti raku

Info

Publication number
SI1997506T1
SI1997506T1 SI200731152T SI200731152T SI1997506T1 SI 1997506 T1 SI1997506 T1 SI 1997506T1 SI 200731152 T SI200731152 T SI 200731152T SI 200731152 T SI200731152 T SI 200731152T SI 1997506 T1 SI1997506 T1 SI 1997506T1
Authority
SI
Slovenia
Prior art keywords
chemosensibilization
inhibitor
treatment
anticancer drugs
refractory tumors
Prior art date
Application number
SI200731152T
Other languages
English (en)
Inventor
Rodriguez Silvio Ernesto Perea
Negrin Yasser Perera
Ulloa Arielis Rodriguez
Valdes Jeovanis Gil
Gomez Yassel Ramos
Serra Lila Rosa Castellanos
Nunez Lazaro Hiram Betancourt
Puente Aniel Sanchez
De Cossio Dorta Duque Jorge Fernandez
Castro Boris Ernesto Acevedo
Lopez Luis Javier Gonzalez
Perez Vladimir Besada
Daniel Fernando Alonso
Daniel Eduardo Gomez
Original Assignee
Centro De Ingenieria Genetica Y Biotecnologia
Biorec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Ingenieria Genetica Y Biotecnologia, Biorec S.A. filed Critical Centro De Ingenieria Genetica Y Biotecnologia
Priority claimed from EP07711104A external-priority patent/EP1997506B8/en
Publication of SI1997506T1 publication Critical patent/SI1997506T1/sl

Links

SI200731152T 2006-02-28 2007-02-28 Uporaba CK2 inhibitorja za zdravljenje in kemosenzibilizacijo refraktarnih tumorjev na zdravila proti raku SI1997506T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU20064920 2006-02-28
EP07711104A EP1997506B8 (en) 2006-02-28 2007-02-28 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs
PCT/CU2007/000010 WO2007098719A1 (es) 2006-02-28 2007-02-28 Combinación farmaceutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas

Publications (1)

Publication Number Publication Date
SI1997506T1 true SI1997506T1 (sl) 2013-03-29

Family

ID=47633906

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731152T SI1997506T1 (sl) 2006-02-28 2007-02-28 Uporaba CK2 inhibitorja za zdravljenje in kemosenzibilizacijo refraktarnih tumorjev na zdravila proti raku

Country Status (4)

Country Link
DK (1) DK1997506T3 (sl)
ES (1) ES2398586T3 (sl)
PT (1) PT1997506E (sl)
SI (1) SI1997506T1 (sl)

Also Published As

Publication number Publication date
ES2398586T3 (es) 2013-03-20
DK1997506T3 (da) 2013-02-11
PT1997506E (pt) 2013-02-11

Similar Documents

Publication Publication Date Title
HK1132451A1 (en) Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
IL248204A0 (en) Combined treatment of tumors expressing 38cd
PL2601962T3 (pl) Schemat dawkowania LAG-3 do stosowania w leczeniu raka
EP1962839A4 (en) ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER
PT2322221E (pt) Composição farmacêutica para tratamento e prevenção de cancro
EP2313091A4 (en) PHARMACEUTICAL COMPOSITIONS WITH RET-HEMMERN AND METHOD FOR THE TREATMENT OF CANCER
GB2454118B (en) Hdac inhibitors and hormone targeted drugs for the treatment of cancer
EP2099449A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE
ZA200908477B (en) Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
HK1148284A1 (en) Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions hif
EP2043679A4 (en) CYTOTOXIC T-LYMPHOCYTE INDUCTIVE IMMUNOGENES FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
EP2061503A4 (en) IMMUNOGENS INDUCING THE PRODUCTION OF CYTOTOXIC T CELLS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF CANCER
IL201460A0 (en) Phthalazinone derivatives and their use as medicament to treat cancer
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
IL205608A (en) History of s-triazole-1-ram-benzamide and their use in the preparation of pain medication
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2144887A4 (en) PHARMACEUTICAL FORMS AND METHOD FOR THE TREATMENT OF CANCER
EP2029156A4 (en) POLY THERAPY FOR TREATING CANCER
IL200966A0 (en) Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
PL2331092T3 (pl) Sposoby i kompozycje do podawania 3-halopirogronianiu i związków pochodnych w leczeniu nowotworu
EP2231146A4 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
PL2305300T3 (pl) Kompozycja farmaceutyczna do leczenia i zapobiegania nowotworowi
FR2910324B1 (fr) Nouveau medicament pour le traitement d'un cancer gastrique